...
首页> 外文期刊>Molecular pharmacology. >Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.
【24h】

Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.

机译:Nociceptin和强啡肽A激活类阿片受体样1和Kappa类阿片受体的不同机制。

获取原文
获取原文并翻译 | 示例
           

摘要

To understand how two structurally analogous ligand-receptor systems, the nociceptin/opioid receptor-like 1 (ORL1) and dynorphin A/kappa-opioid receptor 1 (KOR1) systems, achieve selectivity, receptor chimeras were generated and analyzed. Replacing discrete domains located between the N-terminus and top of the third transmembrane helix of the KOR1 by the homologous domains of the ORL1 receptor yields hybrid receptors, which, in comparison with the parent KOR1, display up to 300-fold increased affinity but low sensitivity toward nociceptin, and unaltered (high) affinity and sensitivity toward dynorphin A. These substitutions contribute elements for binding of nociceptin but do not suppress determinants necessary for binding and potency of dynorphin A. More importantly, further replacement in these chimeras of the second extracellular loop with that of the ORL1 receptor fully restores responsiveness to nociceptin without impairing responsiveness to dynorphin A. A bifunctional hybrid receptor has thus been identified that binds and responds to both nociceptin and dynorphin A as efficiently as the ORL1 receptor does to nociceptin and the KOR1 to dynorphin A. Together, these results suggest that distinct peptide activation mechanisms operate in the two receptor systems. In particular, the second extracellular receptor loop appears to be an absolute requirement for activation of the ORL1 receptor by nociceptin, but not for activation of the KOR1 by dynorphin A.
机译:要了解两种结构相似的配体-受体系统,即伤害感受肽/类阿片受体样1(ORL1)和强啡肽A /κ类阿片受体1(KOR1)系统如何实现选择性,产生并分析了受体嵌合体。用ORL1受体的同源域取代KOR1的N末端和第三个跨膜螺旋顶部之间的离散域会产生杂合受体,与亲本KOR1相比,杂合受体的亲和力最多提高300倍,但亲和力低对伤害感受肽的敏感性,以及对强啡肽A的不变(高)亲和力和敏感性。这些取代为伤害感受肽的结合提供了要素,但没有抑制强啡肽A的结合和效力所必需的决定簇。更重要的是,在这些嵌合体中进一步置换了第二个细胞外与ORL1受体形成的环完全恢复了对伤害感受器的响应性,而不会损害对强啡肽A的响应性。因此,已经确定了一种双功能杂合受体,其与伤害感受器和强啡肽A的结合和响应效率与ORL1受体对伤害感受器和KOR1的响应一样有效。强啡肽A。在一起,这些结果表明不同的肽激活机制在两个受体系统中起作用。特别是,第二个细胞外受体环似乎是伤害感受肽激活ORL1受体的绝对要求,而不是强啡肽A激活KOR1的绝对要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号